News Feed Item

Physician-based Point of Care Diagnostics: Products, Players and Outlook to 2017

NEW YORK, Jan. 14, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Physician-based Point of Care Diagnostics: Products, Players and Outlook to 2017

http://www.reportlinker.com/p01081137/Physician-based-Point-of-Care-Diagnostics-Products-Players-and-Outlook-to-2017 .html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

The market for Point-of-Care (POC) diagnostic products used in the physician's surgery was worth approximately US$1.7 billion in 2011 with sectors such as cholesterol testing and tumour markers making the best continued growth in the year. All sectors will see sustained growth over the medium term, with the total addressable market for products that can be potentially used in a physician's office forging ahead to be valued at over US$6.1 billion by 2017.

In the physician's office, POC diagnostics can play a key role in the diagnosis and ongoing monitoring of acute and chronic illnesses, the detection of some types of cancer, the monitoring of patients on anticoagulation drugs, and for general blood and urine testing. It can also play an important role in enabling preventative medicine, which is intended to help curb the increasing incidence of chronic conditions such as diabetes and cardiovascular disease through early detection and identifying patients with risk factors that mean they are likely to develop such conditions in the future.

The benefits for clinicians, patients and health payers are clear. Physician-based testing provides rapid POC diagnosis and faster medical intervention. Healthcare providers are looking for new ways of improving patient outcomes, which in turn reduces the need for more expensive patient care, medications and hospital stays, as well as reducing costs and managing a larger number of patients without increasing staffing levels or numbers of hospital beds.

Challenges remain...

There are several key challenges in the market. Currently, many physicians' offices do not have budgets for in-house diagnostic testing and healthcare funding needs to change in order to provide incentives for doctors to use the products. For this to happen, healthcare providers need evidence that POC diagnostics provide benefits in terms of clinical-usefulness, convenience and cost in order to adopt them. In addition, concerns have also been raised about the accuracy of some POC tests used to diagnose conditions such as influenza. For infectious disease testing, the ongoing development of POC PCR and DNA-based systems is expected to improve on currently-available products. These devices could represent a significant market opportunity for manufacturers, should they be able to reduce the testing time and price point of the products to something suitable for and attractive to physicians. This new January 2013 report delivers a complete analysis

This new 178-page highly-detailed report Physician-based Point-of-Care Diagnostics: Products, Players and Outlook to 2017 provides executives with a complete understanding of the issues which are shaping the market and how they will affect its commercial and clinical development. This is Volume 3 of a 4-Volume study of the whole POC IVD sector to be published late 2012/early 2013. Table of Contents



Physician's Office POC Testing ....2The Role of POC Testing in a Physician's Office ....3Regulatory and Reimbursement Environment ....4CLIA Waiver .4


Fig.1: POC Diagnostics in Relation to the IVD Market, 2011 .6Fig.2: Percentage of POC Diagnostics Market by Product, 2011 .7Regional Perspective ....7Fig.3: Professional POC Diagnostics Market by Region, 2011 .....8Physician's Office POC Testing Market .....8Addressable Markets for Physician's Office POC Testing, 2007-2011 (US$ million) .....10Fig.4: Addressable Markets for Physician's Office POC Testing, 2011 .....10Fig.5: Physician's Office POC Testing Market, 2011 ......11


POC Diagnostics and the Economy . 12The Burden of Chronic Disease and Preventative Medicine . 12Clinical Utility and Accuracy ..... 14POC Diagnostics as a Disruptive Technology ...... 14Emerging Technologies ..... 15Summary: Market Drivers, Restraints and Opportunities 16


Market Leaders for Physician's Office POC Testing Products ....17Select POC Diagnostics Companies' Sales, 2007-2011 (US$ million) ......17Merger and Acquisition Activity ..... 17Key POC Diagnostics Mergers and Acquisitions, 2008-2011 ....18


Addressable Markets for Physician's Office POC Testing, 2011-2017E (US$ million) ...21Growth in the Addressable Markets for Physician's Office POC Testing, 2008-2017E (%) .21Physician's Office POC Testing Market, 2011-2012E (US$ million) ...21Fig.6: Physician's Office POC Testing Market, 2012(E) .22



Diabetes Prevalence and Burden to the Healthcare System 23

Fig.7: Diabetes Prevalence by Geographic Region, 2011-2030 .23

Diabetes Prevalence for the Top 10 Countries, 2011-2030 (million) 24

Diabetes Management and the Role of HbA1c Testing ...25

POC HbA1c Testing Market 27

Fig.8: Global POC HbA1c Testing Market, 2007-2017E (US$ million) ......27

POC HbA1c Products ....27

ApexBio's A1C Express ....27

Alere/Axis-Shield's Afinion HbA1c and NycoCard HbA1c Tests ...27

Bayer's A1CNow Products .....28

Bio-Rad's in2it A1C Analyser 28

DiaSys Diagnostic Systems' InnovaStar .....28

Ceragem Medisys' HbA1c Analysers ...29

EKF Diagnostics' Quo-Lab, Quo-Test and Biosen HbA1c Analysers ...29

Infopia's Easy/Clover A1c 29

Siemens' DCA Vantage Analyser .29

Tosoh Bioscience's G8 HPLC Analyzer .30

In Development ......30


Cholesterol Testing and Preventative Medicine .32

POC Cholesterol Testing Market Dynamics ..33

Fig.9: Global POC Cholesterol Testing Market, 2007-2017E (US$ million) ....34

Fig:10: POC Cholesterol Testing Market by End User, 2011 ......34

Available Products ......35

Alere's Cholestech LDX System .....35

Akers Biosciences' Tri-Cholesterol Check ..35

Chematics' Chemcard Cholesterol Test ......35

General Life Biotechnology's BeneCheck LipidEx ST ...35

Infopia's Lipid Pro . 36

Jant Pharmacal's LipidPlus Lipid Profile and Glucose Test System ...... 36

Miraculins' PreVu Point of Care Skin Sterol Test .... 36

Distribution Agreements .....37

Polymer Technology Systems' CardioChek PA 37

Roche's Accutrend Plus .... 38

Syntron Bioresearch's Venture Total Cholesterol Test 38

Products in Development 38

Roche and Panasonic Healthcare .....38


POC Coagulation Testing Market Dynamics 39

Fig.11: Global POC Coagulation Market, 2007-2017E (US$ million) ......40

The Impact of New-Generation Anticoagulants .. 40

Patient Self-Testing and Issues for Doctors .41

CoaguSense's CoaguSense PT/INR Monitoring System ..... 43

Alere's INRatio2 System ... 43

International Technidyne Corporation's ProTime Microcoagulation System 43

Roche's CoaguChek XS .... 43

Professional Use Products 44

Alere's Axis-Shield Products ... 44

Helena Laboratories' Cascade POC System ..... 44

Instrumentation Laboratory's GEM PCL Plus .. 45

Roche's CoaguChek Systems .. 45

CoaguChek XS Pro .45

CoaguChek XS Plus 45

CoaguChek XS .45

CoaguChek Link ......45

Products in Development 46

Bio-AMD's COAG . 46

Siemens/Universal Biosensors' POC Coagulation Tests ..... 46


Multi-Functional POC Clinical Chemistry Analysers .47

Handheld POC Analysers Suitable for Use by Physicians ...47

Abaxis' Piccolo xpress ...47

Abbott's i-STAT System .48

Alere/Axis-Shield's Afinion POC System ...49

Alere/Axis-Shield's NycoCard System 49

Benchtop Systems Suitable for Physician's Laboratories .. 50

Alfa Wassermann's ACE Clinical Chemistry Systems ...50

Arkray's SpotChem Systems ......50

SpotChem Test Strips ....51

Audit Diagnostics' Liqui-Stat System 51

DiaSys Diagnostic Systems' InnovaStar ....51

Horiba's ABX Pentra Clinical Chemistry Analysers 52

Ortho-Clinical Diagnostics' VITROS DT60 II Chemistry System .52

Qualigen's FastPack IP System ....52

Samsung's LABGEO Clinical Chemistry Analysers .52

Tosoh Bioscience's AIA Immunoassay Analysers ..52

POC Haematology and Haemoglobin Analysers 53

POC Haemoglobin Systems .....53

POC Analyser Accuracy ..53

ACON Laboratories' Mission Hb Hemoglobin Testing Systems .54

ApexBio's HemoSmart Haemoglobin Screening System ...54

Audit Diagnostics' Hb-Stat ..54

Ceragem Medisys' CERA-CHEK Hb Plus ....54

EKF Diagnostics' Products ....54

General Life Biotechnology's BeneCheck Hb Hemoglobin Test System 55

OrSense's Glasswing and NBM 200 Systems ..55

Quest Diagnostics' HemoCue Haemoglobin Systems .56

URIT Medical's URIT-12 Hemoglobin Meter ....57


Abaxis' MetLyte Plus CRP and BioChemistry Panel Plus .58

Alere/Axis-Shield ..59

bioMérieux bioNexia CRP Test .59

LifeAssays' CRP .....59

Medix Biochemica's Actim CRP 59

Orion Diagnostica's QuikRead and QuikRead go Systems ....59


Current Market Dynamics ..61

Fig.12: Market for POC Infectious Disease Tests used in a Physician's Office, 2007-2017E (US$ million) 61

POC Influenza Testing .61

Performance and Use of Rapid Influenza Tests in the US .. 62

CDC Recommendations 62

CDC: Influenza Prevalence and Test Accuracy ......63

POC Influenza Testing Market 63

Future Prospects .. 64

CLIA-Waived Flu Detection Products .. 64

Alere's Influenza Tests ..64

Becton Dickinson's BD Veritor System ......64

Quidel's Sofia Analyzer and Sofia Influenza A+B Fluorescent Immunoassays ....65

Quidel's QuickVue Influenza Tests .....65

SA Scientific's SAS FluAlert .65

Other POC Flu Detection Products ...... 65

bioMérieux' bioNexia Influenza A+B Tests ....66

IQuum's Liat Influenza A/B Assay and the Liat Analyzer ...66

Jant Pharmacal's Accutest Flu Test ....67

Medix Biochemica's Actim Influenza A&B ......67

Meridian Bioscience's TRU FLU ...67

Mizuho Medy's Quick Chaser Flu A,B .67

OraSure Technologies' OraSure QuickFlu Rapid Flu A+B Test ...67

Princeton BioMeditech's BioSign Flu A+B .....67

Response Biomedical's Influenza A+B Test ....68

Sekisui Diagnostics' OSOM Influenza A & B Test ...68

Products in Development 68

Chembio's DPP Influenza Tests ...68

Cepheid's GeneXpert ....69

Lucigen's Nucleic Acid-Based POC Test ....69

Respiratory Syncytial Virus ......69

Quidel's Sofia RSV Fluorescent Immunoassay .70

Quidel's QuickVue RSV 10 .71

Response Biomedical's RSV Test ....71

Other Respiratory Tests .....71

Ani Biotech's Biocard Chlamydia Pneumoniae IgM Test .....71

GenBio's ImmunoFLOW Mycoplasma IgM Test ..... 72

Group A Streptococcus Tests ....72

Currently-Available POC Strep A Tests ...73

Quidel's Sofia Strep A Fluorescent Immunoassay 73

H. pylori Tests .74

Currently-Available H. pylori Tests . 74

Exalenz Bioscience's BreathID System 75

Otsuka America Pharmaceutical's BreathTek UBT .75

Mononucleosis Tests ...76

Currently-Available POC Mono Tests .....76

Rotavirus and Adenoviral Enteritis Tests .....76

Ani Biotech's Biocard Tests ......76

Meridian Bioscience ImmunoCard STAT! Rotavirus ..... 77

Nicox/Rapid Pathogen Screening's AdenoPlus .... 77

Orion Diagnostica's Diarlex, Rotalex and Adenolex Tests . 77

Women's Heath Diagnostics .....77

Ani Biotech's Biocard Candida and Trichomonas Tests ...... 77

Gryphus Diagnostics' BVBLUE ...... 77

Quidel's QuickView Chlamydia Test ... 78

RunBio Biotech's Tests ...... 78

Savyon Diagnostics' SavvyCheck . 78


Fig.13: Global POC Tumour Markers Market, 2007-2017E (US$ million) ......79

Prostate Specific Antigen Tests 80

Available Tests 81

Mediwatch's PSAwatch 81

OPKO Health's OPKO Diagnostics Platform ....82

Occult Blood Testing ...82

ACON Laboratories' Mission FOB Reagent Strips . 83

Aerscher Diagnostics' HemaPrompt .. 83

Alere's Tests .... 83

Beckman Coulter's Hemoccult Tests .. 83

Biomerica's EZ Detect 83

bioMérieux' bioNexia FOBplus ..... 84

Helena Laboratories' ColoCare ..... 84

Immunostics' Hema-Screen ... 84

Orion Diagnostica's QuikRead System and Orion Q-flow FOB ...... 84

Princeton BioMeditech's BioSign iFOBTest ..... 84

Quest Diagnostics' InSure Quik F I T ... 85

Quidel's QuickVue iFOB ... 85

Other Available FOB Tests ...... 86

Gastric Occult Blood Tests 86

CEA Testing .....87

Alpha Fetoprotein Testing .87

Bladder Cancer Testing ......87

Alere's Matritech NMP22 BladderChek Test .... 88

bioMérieux' bioNexia BTA ...... 88

Mediwatch's Bladderwatch BTA Test .. 88

Novel Products in Development .....88

Bioscience Ventures/ Serascience's POC Myeloma Test ..... 88

Guided Therapeutics' Non-Invasive Cancer Diagnostic Products 88

LuViva Advanced Cervical Scan .88

Oesophageal and Other Cancer Detection ......89

Infopia's Cancer Diagnosing Sensor ... 90


Fig.9: Global POC Urinalysis Market, 2007-2017E (US$ million) .....92

Key Urine Analysis Test Strips ..92

Product Highlights ......92

77 Elektronika's DocUReader 2 and DocuReader 2 Pro ......92

ACON Laboratories' Mission Products .93

Arkray's Products ..93

PocketChem UA ......93


DiaScreen 50 Urine Chemistry Analyser and DiaScreen Reagent Strips 93

Roche's Products ...93

Urisys 1100 Urine Analyser ..93

Chemstrip Criterion II Analyzer ..94

Chemstrips/Combur-Test Strips .94

Siemens' Products 94

Clinitek Status+ .....94

Clinitek Status Connect .94

Multistix10 SG Reagent Strips ....94

RAPIDComm Data Management and Connectivity Solution ....95

Microalbumin Testing .95

Axis-Shield's Afinion ACR Test 95

Biomerica's Fortel Microalbumin Screening-OTC Test 96

Orion Diagnostica's QuikRead U-ALB . 96

Quest Diagnostics' HemoCue Albumin 201 System .... 96

Sekisui Diagnostics' OSOM ImmunoDip Urinary Albumin Test ..... 96

Siemens' Clinitek Microalbumin Strips ..... 96


Alere Heart Check System for Heart Failure Monitoring 97

Liver Function Testing .97

Exalenz Bioscience's BreathID System ...... 97

BreathID Methacetin Breath Test ......98

Infopia's Pioneer POCT Liver Test Sensor .. 98

Thyroid Tests ..98

Jant Pharmacal's Accutest TSH .... 98

Screening Devices Canada's ThyroChek ... 98

Ani Biotech's Biocard Coeliac Tests .99

Rapid Pathogen Screening's InflammaDry ..99

Products in Development ...... 100

Akers Biosciences' BreathPulmo Health Check and Breath Asthma Check 100

POC Breath Asthma Check .100


Applied Nanodetectors' Sensor Array Platform ......101

Ativa Medical's POC System ....101

Bio-AMD's MPR ...102

Biosensia's RapiPlex .102

Cepheid's GeneXpert 103

MagnaBioSciences' MICT On-Site System ..104

Molecular Vision .104

MycroLab 105

OPKO Health's OPKO Diagnostics Platform ......106

pes diagnosesysteme' respons IQ .106

Philips' Minicare .107

Radisens Diagnostics' POC Platform ...108

T2 Biosystems' T2Dx System ..108

T2Hemostasis Assay 109

Tyrian Diagnostics' DiagnostIQ ....110



Abaxis .....117

Piccolo xpress 117

Financial Performance ....118

Abaxis Operating Results, 2007-2012 (US$ million) . 118

Latest Results 118

Akers Biosciences ......119

Recent Key Events .... 119

Current Products 120

PIFA Heparin/PF4 and PIFA PLUSS Rapid Assays 120

Tri-Cholesterol Check ..120

Research and Development ..121

BreathPulmo Health Check ...... 121

POC Breath Asthma Check . 121

Current Alliances and Distribution Agreements ..121

PULSE Health . 121

Al Tadawi Medical Equip/PharmaNova Medical Equipment ..122

Fisher HealthCare .122

US Government Service Administration Schedule Contract ...122

Financial Performance ... 122

Akers Biosciences Operating Results, 2007-2011 (US$ thousands) ..... 123

Fig.15: Percentage of Akers' Revenue by Product Type, 2011 123

Alere .124

Recent Key Events .... 124

POC Cardiology Diagnostic Products ...... 125

Alere Heart Check System ..125

Cholestech LDX .....125

INRatio2 System ...125

Axis-Shield POC Products ..... 125

Afinion POC System .... 126

NycoCard 126

Coagulation Products ......127

POC Oncology Products ..127

POC Infectious Disease Tests .127

POC Mergers & Acquisitions . 128

Axis-Shield ....128

Medical Automation Systems' .128

Standard Diagnostics ..128

Assets from Unotech Diagnostics ....128

Mologic, Jinsung Meditech, Biolinker and Long Chain International Corp ..128

Zycare, Medim and Biosyn .129

ACON Laboratories' Rapid Diagnostics Assets .... 129

Matria Healthcare 129

BBI Holdings .129

Other Acquisitions 129

Agreements .130

EKF Diagnostics ....130

Spartan Bioscience ......130

Financial Performance ....131

Alere - Operating Results, 2007-2011 (US$ million) . 132

Fig.16: Percentage of Alere's Revenue by Segment, 2011 ...... 132

Fig.17: Percentage of Alere's Revenue by Region, 2011 .. 132

Alere Professional Diagnostics: Operating Results, 2007-2011 (US$ million) ... 133

Alere Professional Diagnostics: Net Sales & Services Revenue, 2007-2011 (US$ million) ...... 133

Fig.18: Alere Professional Diagnostics: Net Sales & Services Revenue by Product, 2011 . 133

Latest Results ...... 133

Axis Shield - Financial Performance 134

Fig.19: Axis-Shield Revenue by Business Unit, 2010 . 135

Fig.20: Axis-Shield Revenue by Region, 2010 .... 135

Axis-Shield - POC Segment Operating Results, 2006-2010 (£ million) ...... 135

Axis-Shield - POC Sales by Product Line, 2006-2010 (£ million) .. 136

Fig.21: Axis-Shield POC Sales by Product, 2010 . 136

Fig.22: Axis-Shield Afinion Sales by Region, 2010 .... 136

Arkray .....137

Recent Key Events .... 137

POC Testing Products .....137

SpotChem EZ Dry Chemistry Analyser .. 137

SpotChem D-Concept .138

SpotChem CL SB-1440 Automatic Blood Cell Counter ......138

PocketChem BA Blood Ammonia Meters .....138

Urinalysis 139

Current Alliances 139

ELITech Group 139

Beckman Coulter (Danaher) ...140

POC Products ...... 140

Hemoccult Tests ..140

Gastroccult .... 141

International Technidyne Corporation ......142

Products . 142

ProTime Coagulation Systems .. 142

Hemochron Whole Blood Coagulation System .. 142

Current Alliances 143

Roche ...... 143

Financial Performance ... 143

International Technidyne Operating Results, 2004-2009 (US$ million) ....144

Fig.23: International Technidyne Revenue, 2000-2010 (US$ million) 144

Orion Diagnostica ......145

QuikRead 101 System ..... 145

QuikRead go 145

Uricult Dipslide Tests ...... 146

Rotaviral and Adenoviral Enteritis Tests . 146

Financial Performance ....147

Orion Diagnostica - Operating Results, 2007-2011 (EUR million) 147

Meridian Bioscience ..148

TRU FLU and TRU RSV ..... 148

ImmunoCard STAT! HpSA H. pylori Test .. 148

ImmunoCard STAT! Rotavirus ..... 148

ImmunoCard STAT! Strep A .. 148

ImmunoCard STAT! MONO ... 148

ImmunoCard STAT! hCG Combo Test 149

Financial Performance ... 149

Meridian Bioscience - Operating Results, 2008-2012 (US$ million) ....149

Meridian Bioscience - Third-Party Sales by Segment, 2008-2012 (US$ million) .....149

Meridian Bioscience - Operating Income by Segment, 2008-2012 (US$ million) ....149

Fig.24: Meridian Bioscience - Revenue by Segment, 2012 ....150

Meridian Bioscience - European Diagnostics Sales by Country, 2006-2011 (US$ million) .....150

Outlook ...150

Quest Diagnostics ......151

HemoCue Products ...151

Haemoglobin Systems 151

HemoCue Albumin 201 System .... .. . 152

HemoCue White Blood Cell Analyzer ..... 152

HemoCue WBC DIFF .... 153

HemoCue Basic Data Management and Connectivity Software ... 153

Enterix Products . 153

InSure Quik F I T Fecal Immunochemical Test ... .. 153

Litigation with EKF Diagnostics .. 154

Financial Performance ... 154

Quest Diagnostics - Operating Results, 2007-2011 (US$ million) 155

Quest Diagnostics - Sales and Earnings by Category, 2007-2011 (US$ million) ...... 155

Fig.25: Quest Diagnostics - Revenue by Division, 2011 .. 155

Latest Results and Outlook 155

Quidel ....157

Recent Key Events .... 157

Sofia Analyzer and the Sofia Influenza A+B Fluorescent Immunoassay 157

QuickVue Rapid Tests ..... 158

QuickVue Influenza Tests ...158

QuickVue Group A Strep Tests ...158

QuickVue RSV Tests .....158

QuickVue+ Infectious Mononucleosis ... 159

QuickVue iFOB ..... 159

QuickVue H. Pylori gII Test . 159

Financial Performance ... 159

Quidel - Operating Results, 2007-2011 (US$ million) .....160

Quidel - Revenue by Product Type, 2008-2011 (US$ million) 160

Fig.26: Quidel - Revenue by Product Type, 2011 ......160

Fig.27: Quidel - Infectious Disease Revenue, 2005-2011 (US$ million) ...... 161

Quidel - Revenue by Region, 2005-2011 (US$ million) .. 161

Fig.28: Quidel - Revenue by Region, 2011 .. 161

Latest Results ...... 162

Roche Diagnostics .....163

Recent Key Events ....163

CoaguChek Systems 164

CoaguChek XS Pro ......164

CoaguChek XS Plus .....164

CoaguChek XS ......164

CoaguChek Link ....164

Urinalysis 165

Urisys 1100 Urine Analyser 165

Chemstrip Criterion II Analyzer 165

Chemstrips/Combur-Test Strips ......165

Current Alliances and Contracts . 165

Panasonic Healthcare .165

Voluntis ...166

Financial Performance ... 166

Roche Diagnostics Operating Results, 2010-2011 (SFr million) ...166

Fig.29: Roche Diagnostics - Revenue by Product Line, 2011 .167

Fig.30: Roche Professional Diagnostics - Revenue by Region, 2011 ....167

Latest Results 167

Sekisui Diagnostics ...168

Point of Care Tests .... 168

OSOM RSV/Adenovirus Rapid Test ..168

OSOM Influenza A & B Test 168

OSOM H. pylori ....168

OSOM Ultra Strep A .....168

OSOM Strep A 169

OSOM Mono ..169

OSOM Trichomonas Rapid Test .169

OSOM BVBLUE Test ......169

OSOM ImmunoDip Urinary Albumin Test .....169

OSOM Pregnancy Tests ......169

Siemens Healthcare ..170

Products ..170

Diabetes Testing - DCA Vantage Analyser ..... 170

Urinlysis Products 171

RAPIDComm Data Management and Connectivity Solution .. 172

Current Alliances and Supply Contracts .. 172

Universal Biosensors ...172

Premier ...173

Roche ......173

Financial Performance ... 173

Latest Results 173

Thermo Fisher Scientific ..174

Sure-Vue Tests ......174

Remel's Xpect Tests ...174



Sources ...176

Market forecasts .177


• Abaxis

• Akers Biosciences

• Alere

• Arkray

Beckman Coulter (Danaher)

• International Technidyne Corporation

• Orion Diagnostica

• Meridian Bioscience

• Quest Diagnostics

• Quidel

• Roche Diagnostics

• Sekisui Diagnostics

• Siemens Healthcare

• Thermo Fisher Scientific

To order this report:In_Vitro_Diagnostic Industry: Physician-based Point of Care Diagnostics: Products, Players and Outlook to 2017

Nicolas Bombourg


Email: [email protected]

US: (805)652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
@ThingsExpo has been named the Top 5 Most Influential M2M Brand by Onalytica in the ‘Machine to Machine: Top 100 Influencers and Brands.' Onalytica analyzed the online debate on M2M by looking at over 85,000 tweets to provide the most influential individuals and brands that drive the discussion. According to Onalytica the "analysis showed a very engaged community with a lot of interactive tweets. The M2M discussion seems to be more fragmented and driven by some of the major brands present in the...
Traditional on-premises data centers have long been the domain of modern data platforms like Apache Hadoop, meaning companies who build their business on public cloud were challenged to run Big Data processing and analytics at scale. But recent advancements in Hadoop performance, security, and most importantly cloud-native integrations, are giving organizations the ability to truly gain value from all their data. In his session at 19th Cloud Expo, David Tishgart, Director of Product Marketing ...
WebRTC has had a real tough three or four years, and so have those working with it. Only a few short years ago, the development world were excited about WebRTC and proclaiming how awesome it was. You might have played with the technology a couple of years ago, only to find the extra infrastructure requirements were painful to implement and poorly documented. This probably left a bitter taste in your mouth, especially when things went wrong.
SYS-CON Events announced today that Pulzze Systems will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Pulzze Systems, Inc. provides infrastructure products for the Internet of Things to enable any connected device and system to carry out matched operations without programming. For more information, visit http://www.pulzzesystems.com.
Without lifecycle traceability and visibility across the tool chain, stakeholders from Planning-to-Ops have limited insight and answers to who, what, when, why and how across the DevOps lifecycle. This impacts the ability to deliver high quality software at the needed velocity to drive positive business outcomes. In his general session at @DevOpsSummit at 19th Cloud Expo, Eric Robertson, General Manager at CollabNet, will discuss how customers are able to achieve a level of transparency that e...
The Quantified Economy represents the total global addressable market (TAM) for IoT that, according to a recent IDC report, will grow to an unprecedented $1.3 trillion by 2019. With this the third wave of the Internet-global proliferation of connected devices, appliances and sensors is poised to take off in 2016. In his session at @ThingsExpo, David McLauchlan, CEO and co-founder of Buddy Platform, discussed how the ability to access and analyze the massive volume of streaming data from millio...
SYS-CON Events announced today that Interface Masters Technologies, a leader in Network Visibility and Uptime Solutions, will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Interface Masters Technologies is a leading vendor in the network monitoring and high speed networking markets. Based in the heart of Silicon Valley, Interface Masters' expertise lies in Gigabit, 10 Gigabit and 40 Gigabit Eth...
Successful digital transformation requires new organizational competencies and capabilities. Research tells us that the biggest impediment to successful transformation is human; consequently, the biggest enabler is a properly skilled and empowered workforce. In the digital age, new individual and collective competencies are required. In his session at 19th Cloud Expo, Bob Newhouse, CEO and founder of Agilitiv, will draw together recent research and lessons learned from emerging and established ...
Enterprise IT has been in the era of Hybrid Cloud for some time now. But it seems most conversations about Hybrid are focused on integrating AWS, Microsoft Azure, or Google ECM into existing on-premises systems. Where is all the Private Cloud? What do technology providers need to do to make their offerings more compelling? How should enterprise IT executives and buyers define their focus, needs, and roadmap, and communicate that clearly to the providers?
As software becomes more and more complex, we, as software developers, have been splitting up our code into smaller and smaller components. This is also true for the environment in which we run our code: going from bare metal, to VMs to the modern-day Cloud Native world of containers, schedulers and microservices. While we have figured out how to run containerized applications in the cloud using schedulers, we've yet to come up with a good solution to bridge the gap between getting your conta...
One of biggest questions about Big Data is “How do we harness all that information for business use quickly and effectively?” Geographic Information Systems (GIS) or spatial technology is about more than making maps, but adding critical context and meaning to data of all types, coming from all different channels – even sensors. In his session at @ThingsExpo, William (Bill) Meehan, director of utility solutions for Esri, will take a closer look at the current state of spatial technology and ar...
SYS-CON Events announced today that Streamlyzer will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Streamlyzer is a powerful analytics for video streaming service that enables video streaming providers to monitor and analyze QoE (Quality-of-Experience) from end-user devices in real time.
You have great SaaS business app ideas. You want to turn your idea quickly into a functional and engaging proof of concept. You need to be able to modify it to meet customers' needs, and you need to deliver a complete and secure SaaS application. How could you achieve all the above and yet avoid unforeseen IT requirements that add unnecessary cost and complexity? You also want your app to be responsive in any device at any time. In his session at 19th Cloud Expo, Mark Allen, General Manager of...
DevOps theory promotes a culture of continuous improvement built on collaboration, empowerment, systems thinking, and feedback loops. But how do you collaborate effectively across the traditional silos? How can you make decisions without system-wide visibility? How can you see the whole system when it is spread across teams and locations? How do you close feedback loops across teams and activities delivering complex multi-tier, cloud, container, serverless, and/or API-based services?
SYS-CON Media announced today that @WebRTCSummit Blog, the largest WebRTC resource in the world, has been launched. @WebRTCSummit Blog offers top articles, news stories, and blog posts from the world's well-known experts and guarantees better exposure for its authors than any other publication. @WebRTCSummit Blog can be bookmarked ▸ Here @WebRTCSummit conference site can be bookmarked ▸ Here